ARNUITY ELLIPTA

Drug GlaxoSmithKline, LLC.
Total Payments
$200,544
Transactions
12
Doctors
7
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2021 $200,400 2 0
2017 $143.70 10 7

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $200,400 2 99.9%
Food and Beverage $143.70 10 0.1%

Payments by Type

Research
$200,400
2 transactions
General
$143.70
10 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
0000000000000000000000000000000000000000000000000000000000000000217731 GlaxoSmithKline, LLC. $200,400 0

Top Doctors Receiving Payments for ARNUITY ELLIPTA

Doctor Specialty Location Total Records
Altaf Suleman Orlando, FL $200,424 4
Jeffrey Clarke Spokane, WA $27.88 2
, M. D Pediatric Emergency Medicine Orlando, FL $21.13 1
, PH.D., D.O Allergy & Immunology Morgantown, WV $19.07 1
, MD Allergy & Immunology Rock Hill, SC $14.35 1
Justin Yuan Student in an Organized Health Care Education/Training Program Stanford, CA $13.90 1
, MD Internal Medicine Westminster, CA $13.88 1
, M.D Internal Medicine Cincinnati, OH $9.03 1

About ARNUITY ELLIPTA

ARNUITY ELLIPTA is a drug associated with $200,544 in payments to 7 healthcare providers, recorded across 12 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..

Payment data is available from 2017 to 2021. In 2021, $200,400 was paid across 2 transactions to 0 doctors.

The most common payment nature for ARNUITY ELLIPTA is "Unspecified" ($200,400, 99.9% of total).

ARNUITY ELLIPTA is associated with 1 research study, including "0000000000000000000000000000000000000000000000000000000000000000217731" ($200,400).